Posts Tagged ‘ Rep. Cliff Stearns ’

FDA Misses Deadline to File Financials for Review

Jan 24th, 2012 | By
FDA Misses Deadline to File Financials for Review

The U.S. Food and Drug Administration (FDA) was supposed to submit a new agreement to lawmakers on  January 15, concerning how much funding it will need next year to review medical devices and conduct product reviews. Bloomberg reports (here) no new agreement was filed – the FDA essentially missed its deadline. That may hurt the
[continue reading...]



We hope you find this a helpful resource. National News Editor, Jane Akre, began MDND with the hope of providing the latest news, information and perspective from the regulatory, industry and patient point of view, something that goes under-reported in much of the coverage of medical devices. The public is just now becoming aware that many devices do not undergo the same scrutiny as prescription drugs and are instead grandfathered in under an FDA loophole that has gone largely unchanged since the 1970s. As a result, patients become the post-market clinical trial subjects, and many suffer devastating and permanent injuries.